STVN
HEALTHCAREStevanato Group Spa
Live · NYSE · May 9, Close
What's Moving STVN Today?
No stock-specific AI insight has been generated for STVN yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$19.00
Fundamentals
Trading
STVN News
20 articles- Stevanato (STVN) Q1 2026 Earnings TranscriptMotley Fool·May 8, 2026
- Stevanato Group S.p.A. Q1 2026 Earnings Call SummaryMoby·May 8, 2026
- Stevanato Group (STVN) Q1 Earnings and Revenues Beat EstimatesYahoo Finance·May 7, 2026
- Stevanato Group Delivers 7% Revenue Growth (10% at Constant Currency) for the First Quarter of Fiscal 2026Yahoo Finance·May 7, 2026
- A Look At Stevanato Group’s (NYSE:STVN) Valuation After Its Recent Share Price ReboundYahoo Finance·May 7, 2026
- Madrigal (MDGL) Reports Q1 Loss, Beats Revenue EstimatesYahoo Finance·May 6, 2026
- Stevanato Group to Participate in Three Upcoming Investor ConferencesYahoo Finance·May 4, 2026
- Analysts Estimate Harrow (HROW) to Report a Decline in Earnings: What to Look Out forYahoo Finance·May 4, 2026
- Stevanato Group (STVN) Reports Next Week: Wall Street Expects Earnings GrowthYahoo Finance·Apr 30, 2026
- Here’s Why Stevanato Group Spa (STVN) Declined in Q1Yahoo Finance·Apr 27, 2026
- Why The Stevanato Group (STVN) Investment Story Is Being Reset On GLP 1 And BiologicsYahoo Finance·Apr 25, 2026
- Stevanato Group to Report First Quarter 2026 Financial Results on May 7, 2026Yahoo Finance·Apr 23, 2026
- Stevanato Group’s (STVN) Core Business Improved Despite a 22% Pull Back in Q4Yahoo Finance·Apr 1, 2026
- Here’s Why Artisan Small Cap Fund Remains Invested in Stevanato Group (STVN)Yahoo Finance·Mar 17, 2026
- Stevanato Group to Participate in the KeyBanc Capital Markets Virtual Healthcare ForumYahoo Finance·Mar 12, 2026
- Is It Time To Reassess Stevanato Group (STVN) After The Recent Share Price ReboundYahoo Finance·Mar 5, 2026
- Stevanato Group SpA (STVN) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ...Yahoo Finance·Mar 4, 2026
- Stevanato Group Q4 Earnings Call HighlightsMarketbeat·Mar 4, 2026
- Stevanato Group S.p.A. Q4 2025 Earnings Call SummaryMoby·Mar 4, 2026
- Stevanato Group (STVN) Surpasses Q4 Earnings and Revenue EstimatesYahoo Finance·Mar 4, 2026
All 20 articles loaded
Price Data
52-Week Range
$19.00
Fundamentals
Trading
About Stevanato Group Spa
Stevanato Group SpA (STVN) is a prominent global leader in advanced drug delivery systems, offering innovative integrated solutions specifically designed for the pharmaceutical and biotechnology industries. The company specializes in the design and production of high-quality glass and polymer packaging for injectable medications, enhancing the efficiency and reliability of drug administration. With a dedicated focus on quality, sustainability, and technological advancement, Stevanato is strategically positioned to capitalize on the increasing demand within the biopharmaceutical sector, making it an appealing investment opportunity for institutional investors seeking exposure to healthcare innovation.